Skin Cancers Completed Phase 2 Trials for Talabostat (DB06182)

Also known as: Cancer of Skin / Skin Cancer / [X]Malignant neoplasm of skin, unspecified / Skin malignant neoplasm NOS / Malignant skin neoplasm NOS / Skin neoplasms malignant and unspecified / Skin neoplasm malignant NOS / Skin neoplasm malignant

IndicationStatusPhase
DBCOND0046599 (Skin Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00083252Study of Talabostat and Cisplatin in Advanced MelanomaTreatment
NCT00083239Study of Talabostat in Advanced MelanomaTreatment